Drug Development Webinars
-
The Increasing Demand For Sterile Filtration Of High Concentration Drugs
3/21/2024
Explore the current trends and challenges with manufacturing high-concentration drug products and an approach to performing extensive filterability trials without a high quantity of expensive product.
-
Identify And Mitigate Absorption Risks With PBPK Modeling
3/12/2024
See how PBPK models combined with custom and off-the-shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.
-
Idea To Clinic: Accelerate Your Manufacturing Timeline To FIH Studies
3/11/2024
Translating novel drug discoveries into clinical trials remains a complex endeavor. Learn how a CDMO with cutting-edge technologies can facilitate a smooth path from discovery to FIH studies.
-
Breaking Bad Manufacturing Habits: Attaining Sustainable API Production
3/6/2024
Sustainability is a growing issue in the pharmaceutical industry. Review strategies for reducing your carbon footprint and learn how the right CDMO can help drive the sustainable manufacture of APIs.
-
Technology To Overcome Absorption Hurdles And Solubility Limitations
3/6/2024
For poorly soluble drugs, overcoming absorption hurdles can hinder development. KinetiSol™ Technology empowers researchers to overcome solubility limitations and accelerate drug development.
-
A Closed And Automated Solution For Cell Therapy Manufacturing
3/1/2024
Streamline your cell therapy manufacturing process and workflow by automating and closing your cell isolation, cell harvest, and formulation with a system designed to offer you versatility.
-
Building Better Degraders: Targeted Protein Degradation Partners
3/1/2024
Learn from industry experts about the latest advances in chemical building blocks for protein degradation, including warheads, linkers, and ligands, and their role in constructing superior degrades.
-
Advancements In Process And Payload Development
2/29/2024
Continuous advancements in the process and payload development of ADCs and next-generation bioconjugates have the potential to progress targeted therapeutics and improve patient treatment options.
-
Don’t Fear CDMO Or Facility Change
2/15/2024
One of our most experienced outsourcing professionals pleads with Outsourced Pharma readers to make the changes necessary to bring about optimal outsourcing.
-
FTEs, Fees-For-Service, Or Time-And-Materials?
2/15/2024
All three of our expert panelists have opinions and suggestions for Outsourced Pharma readers when it comes to how to hire the skilled workforce at a CDMO.